Sertraline Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Sertraline Hydrochloride
HEALTH CANADA PATENTS

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Sertraline Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

65 API Suppliers, 25 USDMF, 25 CEP/COS, 7 JDMF, 23 EU WC, 14 KDMF, 20 NDC API, 30 Listed Suppliers, $ API Reference Price

65 API Suppliers
25 USDMF
25 CEP/COS
7 JDMF
23 EU WC
14 KDMF
20 NDC API
30 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

16 Intermediates Suppliers

16 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

517 FDF Dossiers, 96 FDA Orange Book, 255 Europe, 54 Canada, 34 Australia, 25 South Africa, 53 Listed Dossiers

517 FDF Dossiers
96 FDA Orange Book
255 Europe
54 Canada
34 Australia
25 South Africa
53 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE

TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 25MG BASE
TABLET;ORAL - EQ 50MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 3 DKSH, 2 Jai Radhe Sales, 5 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 37 Direct Compression, 32 Controlled & Modified Release, 31 Disintegrants & Superdisintegrants, 27 Solubilizers, 23 Thickeners and Stabilizers, 22 Granulation, 21 Film Formers & Plasticizers, 18 Topical, 17 Parenteral, 17 Lubricants & Glidants, 17 Co-Processed Excipients, 8 Taste Masking, 8 Emulsifying Agents, 7 API Stability Enhancers, 6 Chewable & Orodispersible Aids, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Surfactant & Foaming Agents

77 Fillers, Diluents & Binders
52 Coating Systems & Additives
37 Direct Compression
32 Controlled & Modified Release
31 Disintegrants & Superdisintegrants
27 Solubilizers
23 Thickeners and Stabilizers
22 Granulation
21 Film Formers & Plasticizers
18 Topical
17 Parenteral
17 Lubricants & Glidants
17 Co-Processed Excipients
8 Taste Masking
8 Emulsifying Agents
7 API Stability Enhancers
6 Chewable & Orodispersible Aids
5 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents
3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 217 Finished Drug Prices, 9 Annual Reports

2 US Medicaid Prescriptions
217 Finished Drug Prices
9 Annual Reports

MARKET PLACE

17 APIs, 6 FDF Dossiers

17 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 11 Others

4 EDQM
3 USP
11 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ API Ref.Price (USD/KG) : 127 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Pfizer Canada Inc.

filter Patent Reset all filters

5 All

01 52029065

filter Product Reset all filters

5 All

01 5Sertraline Hydrochloride

filter Dosage Reset all filters

5 All

01 5Capsule

filter Exp Date Reset all filters

5 All

01 52010-10-31

Product Main Page

01

Pfizer Canada Inc.

Sertraline Hydrochloride

BioFlorida Conference

Not Confirmed

Pfizer Canada Inc.

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-10-31

Date Granted : 1994-11-08

Sertraline Hydrochloride

Brand Name : ZOLOFT

Patent Number : 2029065

Filing Date : 1990-10-31

Strength per Unit : 100mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-10-31

Date Granted : 1994-11-08

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada Inc.

Sertraline Hydrochloride

BioFlorida Conference

Not Confirmed

Pfizer Canada Inc.

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-10-31

Date Granted : 1994-11-08

Sertraline Hydrochloride

Brand Name : ZOLOFT

Patent Number : 2029065

Filing Date : 1990-10-31

Strength per Unit : 150mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-10-31

Date Granted : 1994-11-08

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada Inc.

Sertraline Hydrochloride

BioFlorida Conference

Not Confirmed

Pfizer Canada Inc.

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-10-31

Date Granted : 1994-11-08

Sertraline Hydrochloride

Brand Name : ZOLOFT

Patent Number : 2029065

Filing Date : 1990-10-31

Strength per Unit : 200mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-10-31

Date Granted : 1994-11-08

Portfolio PDF

Product Web Link

Digital Content

04

Pfizer Canada Inc.

Sertraline Hydrochloride

BioFlorida Conference

Not Confirmed

Pfizer Canada Inc.

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-10-31

Date Granted : 1994-11-08

Sertraline Hydrochloride

Brand Name : ZOLOFT

Patent Number : 2029065

Filing Date : 1990-10-31

Strength per Unit : 25mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-10-31

Date Granted : 1994-11-08

Portfolio PDF

Product Web Link

Digital Content

05

Pfizer Canada Inc.

Sertraline Hydrochloride

BioFlorida Conference

Not Confirmed

Pfizer Canada Inc.

BioFlorida Conference

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-10-31

Date Granted : 1994-11-08

Sertraline Hydrochloride

Brand Name : ZOLOFT

Patent Number : 2029065

Filing Date : 1990-10-31

Strength per Unit : 50mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2010-10-31

Date Granted : 1994-11-08

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?